Allergan

Allergan Recent News

Allergan Going After Gilead? Gabelli Says CEO 'Playing Chess While The Market Is Playing Checkers'
Allergan's Tobira Acquisition Represents The Highest Premium Ever Paid In Biopharma
This Pharmaceutical CEO Just Laid Out The 4 Principles Of Its 'Social Contract' With Shareholders
Oracle's $14 Billion Corporate Bond Offering Is Big, But These 5 Deals Were Bigger
Carl Icahn's New Stake In Allergan
Allergan Announces Acquisition Of Topokine Therapeutics, Highlights Fat Reduction Development Program
Barron's Picks And Pans: Ford, Intel, Sealed Air And More
Shire Selling Off After Inversion Announcement
Why Valeant's New CEO Could Be An Allergan Exec
Allergan Gains 1.50% Following Q4 Beat, Company Updates On M&A Activity
Credit Suisse Offers 2016 U.S. Large-Cap Pharma Outlook
9 Healthcare Picks For 2016
Clinton, Sanders And Trump Not Big Fans Of The Pfizer-Allergan Deal
Pfizer, Allergan In 'Final Innings' Of Merger Talks
Is Teva A Better Target For Mylan Than Perrigo? 2 Analysts Share Their Thoughts
Actavis' Growth 'Underappreciated,' Sterne Agee Says
Markets End Week On Positive Note As Investors Are Encouraged By Central Bank Developments In Europe, China
#PreMarket Primer: Friday, November 21: Immigration Reform Could Have Lasting Impact In More Ways Than One
U.S. Markets Recover From Early-Day Losses As Japan's Economy Contracts
All Quiet On The Market Front: Dow, S&P 500, Nasdaq Virtually Flat
Markets Mostly Lower As Americans Head To Vote, Oil Continues To Tumble
Markets Mixed As Oil Continues To Drop
Markets Virtually Flat, Oil Continues To Decline Following Bearish Outlook

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved